| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |